{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:55:58Z","timestamp":1790819758335,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ocular surface diseases (OSDs) are a heterogeneous group of disorders characterized by overlapping inflammatory, vascular, microbial, neuroimmune, and meibomian gland abnormalities that contribute to the onset and persistence of ocular surface symptoms and signs. Conventional symptom-directed therapies do not adequately alleviate refractory meibomian gland dysfunction, Demodex-associated blepharitis, ocular rosacea, recurrent chalazion, and allergic conjunctivitis. Recent evidence suggests that these conditions may share convergent pathological features, including chronic inflammation, abnormal lid-margin vascularity, and microbial or parasitic imbalance. Intense pulsed light (IPL), which was initially used for vascular and inflammatory disorders in dermatology, has emerged as a potential physical therapy that acts through several proposed mechanisms in patients with selected refractory OSDs, including photothermal liquefaction of inspissated meibum, coagulation of abnormal vessels, reduction of Demodex and microbial burden, modulation of inflammatory responses, and possible effects on neuroimmune signaling; however, these mechanisms remain incompletely established. Case series and clinical studies have reported improvements in ocular symptoms, tear film stability, meibomian gland function and drainage, lid-margin inflammation, and chalazion or lesion resolution, particularly when IPL is combined with meibomian gland expression or other adjunctive therapies. However, treatment responses vary across disease phenotypes and standardized treatment parameters, long-term safety data, and high-quality randomized controlled trials remain limited. Anatomical factors, disease severity, glandular structure, and inflammatory status may also influence therapeutic outcomes. Overall, IPL therapy represents a promising but evolving treatment strategy for refractory OSDs. This review summarizes the current knowledge regarding the proposed mechanisms, clinical applications, treatment protocols, limitations, and future directions and provides updated perspectives for the rational use of IPL in OSD management.<\/jats:p>","DOI":"10.1186\/s40662-026-00510-3","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:31Z","timestamp":1790758591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intense pulsed light as a multi-target intervention paradigm for refractory ocular surface diseases: a review"],"prefix":"10.1186","volume":"13","author":[{"given":"Jiayi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"4596","key":"510_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.6836297","volume":"220","author":"RR Anderson","year":"1983","unstructured":"Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524\u20137.","journal-title":"Science"},{"key":"510_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/618206","volume":"2014","author":"D Piccolo","year":"2014","unstructured":"Piccolo D, Di Marcantonio D, Crisman G, Cannarozzo G, Sannino M, Chiricozzi A, et al. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014:618206.","journal-title":"Biomed Res Int."},{"issue":"1","key":"510_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-024-04060-9","volume":"39","author":"R Chen","year":"2024","unstructured":"Chen R, Lu J, Dong J, Zhu Y. Intense pulsed light therapy for ocular surface diseases. Lasers Med Sci. 2024;39(1):111.","journal-title":"Lasers Med Sci"},{"issue":"1","key":"510_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/pho.2014.3819","volume":"33","author":"R Toyos","year":"2015","unstructured":"Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015;33(1):41\u20136.","journal-title":"Photomed Laser Surg"},{"issue":"1","key":"510_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1120672120937252","volume":"31","author":"S Jabbehdari","year":"2021","unstructured":"Jabbehdari S, Memar OM, Caughlin B, Djalilian AR. Update on the pathogenesis and management of ocular rosacea: an interdisciplinary review. Eur J Ophthalmol. 2021;31(1):22\u201333.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"510_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/12034754241254051","volume":"28","author":"M Shergill","year":"2024","unstructured":"Shergill M, Khaslavsky S, Avraham S, Kashetsky N, Zaslavsky K, Mukovozov I. A review of intense pulsed light in the treatment of ocular rosacea. J Cutan Med Surg. 2024;28(4):370\u20134.","journal-title":"J Cutan Med Surg"},{"key":"510_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.839908","volume":"9","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Huang X, Lin L, Di M, Chen R, Dong J, et al. Efficacy of intense pulsed light in the treatment of recurrent chalaziosis. Front Med (Lausanne). 2022;9:839908.","journal-title":"Front Med (Lausanne)."},{"issue":"6","key":"510_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270268","volume":"17","author":"R Toyos","year":"2022","unstructured":"Toyos R, Desai NR, Toyos M, Dell SJ. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: a randomized controlled study. PLoS One. 2022;17(6):e0270268.","journal-title":"PLoS one"},{"issue":"4","key":"510_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4103\/IJO.IJO_2836_22","volume":"71","author":"S Gupta","year":"2023","unstructured":"Gupta S, Rahman M, Tibrewal S, Gaur A, Ganesh S, Sangwan VS. Evaluation of dry eyes in children with vernal kerato-conjunctivitis using clinical tests and ocular surface analysis. Indian J Ophthalmol. 2023;71(4):1488\u201394.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"510_CR10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","volume":"52","author":"JD Nelson","year":"2011","unstructured":"Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"510_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.101042","volume":"66","author":"AA Gordon","year":"2020","unstructured":"Gordon AA, Danek DJ, Phelps PO. Common inflammatory and infectious conditions of the eyelid. Dis Mon. 2020;66(10):101042.","journal-title":"Dis Mon"},{"issue":"2","key":"510_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/08820538.2025.2536228","volume":"41","author":"V Anitha","year":"2025","unstructured":"Anitha V, Rhagavan A, Rao SK, Srinivasan B, Kusumesh R, Nallasamy N, et al. \u201cOcular surface disorders in children\u201d: a comprehensive review of pathogenesis, diagnosis, and management. Semin Ophthalmol. 2025;41(2):260\u201376.","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"510_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365.","journal-title":"Ocul Surf"},{"issue":"3","key":"510_CR14","volume":"3","author":"S Cote","year":"2020","unstructured":"Cote S, Zhang AC, Ahmadzai V, Maleken A, Li C, Oppedisano J, et al. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev. 2020;3(3):CD013559.","journal-title":"Cochrane Database Syst Rev"},{"key":"510_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jtos.2023.04.008","volume":"28","author":"A Galor","year":"2023","unstructured":"Galor A, Britten-Jones AC, Feng Y, Ferrari G, Goldblum D, Gupta PK, et al. TFOS lifestyle: impact of lifestyle challenges on the ocular surface. Ocul Surf. 2023;28:262\u2013303.","journal-title":"Ocul Surf"},{"issue":"4","key":"510_CR16","doi-asserted-by":"publisher","first-page":"P50","DOI":"10.1016\/j.ophtha.2023.12.036","volume":"131","author":"A Lin","year":"2024","unstructured":"Lin A, Ahmad S, Amescua G, Cheung AY, Choi DS, Jhanji V, et al. Blepharitis Preferred Practice Pattern\u00ae. Ophthalmology. 2024;131(4):P50\u201386.","journal-title":"Ophthalmology"},{"issue":"3","key":"510_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Ben\u00edtez-del-Castillo J, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100(3):300\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"510_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810229","volume":"23","author":"D Borroni","year":"2022","unstructured":"Borroni D, Paytuv\u00ed-Gallart A, Sanseverino W, G\u00f3mez-Huertas C, Bonci P, Romano V, et al. Exploring the healthy eye microbiota niche in a multicenter study. Int J Mol Sci. 2022;23(18):10229.","journal-title":"Int J Mol Sci"},{"key":"510_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.exer.2017.06.011","volume":"163","author":"S Mizoguchi","year":"2017","unstructured":"Mizoguchi S, Iwanishi H, Arita R, Shirai K, Sumioka T, Kokado M, et al. Ocular surface inflammation impairs structure and function of meibomian gland. Exp Eye Res. 2017;163:78\u201384.","journal-title":"Exp Eye Res"},{"issue":"6","key":"510_CR20","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/09273948.2020.1841804","volume":"29","author":"A Leonardi","year":"2021","unstructured":"Leonardi A, Modugno RL, Salami E. Allergy and dry eye disease. Ocul Immunol Inflamm. 2021;29(6):1168\u201376.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"510_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/02713683.2017.1406525","volume":"43","author":"Y Yin","year":"2018","unstructured":"Yin Y, Liu N, Gong L, Song N. Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients. Curr Eye Res. 2018;43(3):308\u201313.","journal-title":"Curr Eye Res"},{"issue":"1","key":"510_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02261-w","volume":"22","author":"J Huang","year":"2022","unstructured":"Huang J, Guo MX, Xiang DM, Yan LF, Yu Y, Han L, et al. The association of Demodex infestation with pediatric chalazia. BMC Ophthalmol. 2022;22(1):124.","journal-title":"BMC Ophthalmol"},{"key":"510_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","volume":"183","author":"R Liu","year":"2017","unstructured":"Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81\u201390.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"510_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/pho.2017.4402","volume":"36","author":"B Rong","year":"2018","unstructured":"Rong B, Tang Y, Tu P, Liu R, Qiao J, Song W, et al. Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction. Photomed Laser Surg. 2018;36(6):326\u201332.","journal-title":"Photomed Laser Surg"},{"issue":"8","key":"510_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1080\/02713683.2020.1867750","volume":"46","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li J, Wu Y, Lin X, Deng X, Zhao YE. Comparative evaluation in intense pulsed light therapy combined with or without meibomian gland expression for the treatment of meibomian gland dysfunction. Curr Eye Res. 2021;46(8):1125\u201331.","journal-title":"Curr Eye Res"},{"issue":"51","key":"510_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032292","volume":"101","author":"C Liu","year":"2022","unstructured":"Liu C, Zhou Q, Gao ZQ. Efficacy of intense pulsed light and meibomian gland expression treatments in meibomian gland dysfunction: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2022;101(51):e32292.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"510_CR27","first-page":"435","volume":"41","author":"L Li","year":"2023","unstructured":"Li L, Chen J, Qin G, Qi Y, Chen Y, Li M, et al. Tear film lipid layer changes following combined effect of heated eye mask with intense pulsed light therapy for evaporative dry eye: a randomized control study. Photobiomodul Photomed Laser Surg. 2023;41(8):435\u201344.","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"510_CR28","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.2147\/OPTH.S426564","volume":"17","author":"J Chelnis","year":"2023","unstructured":"Chelnis J, Garcia CN, Hamza H. Multi-frequency RF combined with intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2023;17:3089\u2013102.","journal-title":"Clin Ophthalmol"},{"key":"510_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/OPTO.S217639","volume":"11","author":"G Giannaccare","year":"2019","unstructured":"Giannaccare G, Taroni L, Senni C, Scorcia V. Intense pulsed light therapy in the treatment of meibomian gland dysfunction: current perspectives. Clin Optom (Auckl). 2019;11:113\u201326.","journal-title":"Clin Optom (Auckl)."},{"issue":"1","key":"510_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-020-04834-1","volume":"259","author":"X Leng","year":"2021","unstructured":"Leng X, Shi M, Liu X, Cui J, Sun H, Lu X. Intense pulsed light for meibomian gland dysfunction: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):1\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"16","key":"510_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164724","volume":"11","author":"Y Lee","year":"2022","unstructured":"Lee Y, Jang JH, Nam S, Lee K, Kim J, Kim JY, et al. Investigation of prognostic factors for intense pulsed light treatment with a vascular filter in patients with moderate or severe meibomian gland dysfunction. J Clin Med. 2022;11(16):4724.","journal-title":"J Clin Med"},{"issue":"7","key":"510_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/08164622.2021.1976595","volume":"105","author":"S Zarei-Ghanavati","year":"2022","unstructured":"Zarei-Ghanavati S, Hassanzadeh S, Azimi Khorasani A, Ehsaei A, Bakhtiari E. Efficacy of five-flash intense pulsed light therapy technique in patients with meibomian gland dysfunction. Clin Exp Optom. 2022;105(7):687\u201393.","journal-title":"Clin Exp Optom"},{"issue":"1","key":"510_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/ICL.0000000000000958","volume":"49","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Gargallo-Mart\u00ednez B, S\u00e1nchez-Gonz\u00e1lez MC, S\u00e1nchez-Gonz\u00e1lez JM. Intense pulse light combined with low-level light therapy in dry eye disease: a systematic review. Eye Contact Lens. 2023;49(1):8\u201313.","journal-title":"Eye Contact Lens"},{"issue":"8","key":"510_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256533","volume":"16","author":"Q Li","year":"2021","unstructured":"Li Q, Liu J, Liu C, Piao J, Yang W, An N, et al. Effects of intense pulsed light treatment on tear cytokines and clinical outcomes in meibomian gland dysfunction. PLoS One. 2021;16(8):e0256533.","journal-title":"PLoS One"},{"issue":"1","key":"510_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-024-04154-4","volume":"39","author":"YY Jeon","year":"2024","unstructured":"Jeon YY, Bae S, Chung HS, Kim JY, Lee H. Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD. Lasers Med Sci. 2024;39(1):203.","journal-title":"Lasers Med Sci"},{"issue":"10","key":"510_CR36","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/1744666X.2024.2358157","volume":"20","author":"Y Huo","year":"2024","unstructured":"Huo Y, Huang X, Lin L, Yang S, Qin Z, Yirui Z, et al. The effect of intense pulsed light combined with topical 0.05% cyclosporine A eyedrops in the treatment of Sj\u00f6gren\u2019s syndrome related dry eye. Expert Rev Clin Immunol. 2024;20(10):1261\u20137.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"510_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44000-0","volume":"9","author":"M Choi","year":"2019","unstructured":"Choi M, Han SJ, Ji YW, Choi YJ, Jun I, Alotaibi MH, et al. Meibum expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear inflammatory cytokines. Sci Rep. 2019;9(1):7648.","journal-title":"Sci Rep"},{"issue":"1","key":"510_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/jop.2024.0099","volume":"41","author":"G Hoarau","year":"2025","unstructured":"Hoarau G, Best AL, Zina-Meziou S, Benali-Abdallah M, Loukil M, Bouvet M, et al. Effects of intense pulsed light on presumed neuropathic pain associated with meibomian gland dysfunction: a before\u2013after study. J Ocul Pharmacol Ther. 2025;41(1):24\u201332.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"510_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2025.102456","volume":"48","author":"JC Chiang","year":"2025","unstructured":"Chiang JC, Dremin V, Semp DA, Lam HY, Ting PW, Ayaz M, et al. Low-level light therapy alone versus combination therapy with intense pulsed light in the treatment of dry eye disease with meibomian gland dysfunction: a randomised paired-eye and mechanism of action trial. Contact Lens Anterior Eye. 2025;48(6):102456.","journal-title":"Contact Lens Anterior Eye"},{"issue":"8","key":"510_CR40","first-page":"472","volume":"38","author":"HA Fishman","year":"2020","unstructured":"Fishman HA, Periman LM, Shah AA. Real-time video microscopy of in vitro Demodex death by intense pulsed light. Photobiomodul Photomed Laser Surg. 2020;38(8):472\u20136.","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"510_CR41","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.2147\/OPTH.S521989","volume":"9","author":"S Farrant","year":"2025","unstructured":"Farrant S, Giannaccare G, Lim C, Coco G. Intense pulsed light combined with low level blue and red light therapy for demodex-associated blepharitis. Clin Ophthalmol. 2025;9:2575\u201385.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"510_CR42","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s11596-019-2108-1","volume":"39","author":"SN Cheng","year":"2019","unstructured":"Cheng SN, Jiang FG, Chen H, Gao H, Huang YK. Intense pulsed light therapy for patients with meibomian gland dysfunction and ocular demodex infestation. Curr Med Sci. 2019;39(5):800\u20139.","journal-title":"Curr Med Sci"},{"key":"510_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/OPTH.S139894","volume":"11","author":"SJ Dell","year":"2017","unstructured":"Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol. 2017;11:1167\u201373.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"510_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","volume":"51","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51(4):249\u201353.","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"510_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102344","volume":"48","author":"KE Chan","year":"2025","unstructured":"Chan KE, Lau BSR, Lim BXH, Du R, Giannaccare G, Tong L, et al. Low-level light therapy and intense pulse light therapy in meibomian gland dysfunction. A systematic review and meta-analysis. Contact Lens Anterior Eye. 2025;48(2):102344.","journal-title":"Contact Lens Anterior Eye"},{"issue":"7","key":"510_CR46","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s10103-015-1787-5","volume":"30","author":"E Cuerda-Galindo","year":"2015","unstructured":"Cuerda-Galindo E, D\u00edaz-Gil G, Palomar-Gallego MA, Linares-Garc\u00edaValdecasas R. Intense pulsed light induces synthesis of dermal extracellular proteins in vitro. Lasers Med Sci. 2015;30(7):1931\u20139.","journal-title":"Lasers Med Sci"},{"issue":"9","key":"510_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00403-021-02283-2","volume":"314","author":"AFS Sales","year":"2021","unstructured":"Sales AFS, Pandolfo IL, De Almeida Cruz M, Parisi JR, Garcia LA, Martignago CCS, et al. Intense pulsed light on skin rejuvenation: a systematic review. Arch Dermatol Res. 2021;314(9):823\u201338.","journal-title":"Arch Dermatol Res"},{"issue":"Suppl 1","key":"510_CR48","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.15171\/jlms.2019.S12","volume":"10","author":"B Barikbin","year":"2019","unstructured":"Barikbin B, Akbari Z, Vafaee R, Razzaghi Z. The efficacy of IPL in periorbital skin rejuvenation: an open-label study. J Lasers Med Sci. 2019;10(Suppl 1):S64-7.","journal-title":"J Lasers Med Sci."},{"issue":"3","key":"510_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10103-010-0870-1","volume":"26","author":"J Huang","year":"2011","unstructured":"Huang J, Luo X, Lu J, Chen J, Zuo C, Xiang Y, et al. IPL irradiation rejuvenates skin collagen via the bidirectional regulation of MMP-1 and TGF-\u03b21 mediated by MAPKs in fibroblasts. Lasers Med Sci. 2011;26(3):381\u20137.","journal-title":"Lasers Med Sci"},{"key":"510_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/OPTH.S280707","volume":"15","author":"S Sagaser","year":"2021","unstructured":"Sagaser S, Butterfield R, Kosiorek H, Kusne Y, Maldonado J, Fautsch MP, et al. Effects of intense pulsed light on tear film TGF-\u03b2 and microbiome in ocular rosacea with dry eye. Clin Ophthalmol. 2021;15:323\u201330.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"510_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/ICO.0000000000002997","volume":"42","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, Pellegrini M, Carnovale Scalzo G, Borselli M, Ceravolo D, Scorcia V. Low-level light therapy versus intense pulsed light for the treatment of meibomian gland dysfunction: preliminary results from a prospective randomized comparative study. Cornea. 2023;42(2):141\u20134.","journal-title":"Cornea"},{"issue":"1","key":"510_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10792-025-03792-z","volume":"45","author":"Y Han","year":"2025","unstructured":"Han Y, Zhang S, Xie X, Ren D, Zhang Y, Guo X. Long-term efficacy of three treatments for severe MGD: a comparative study in chinese patients. Int Ophthalmol. 2025;45(1):443.","journal-title":"Int Ophthalmol."},{"issue":"6","key":"510_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57060619","volume":"57","author":"L Solomos","year":"2021","unstructured":"Solomos L, Bouthour W, Malcl\u00e8s A, Thumann G, Massa H. Meibomian gland dysfunction: intense pulsed light therapy in combination with low-level light therapy as rescue treatment. Medicina (Kaunas). 2021;57(6):619.","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"510_CR54","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.4103\/IJO.IJO_2834_22","volume":"71","author":"S D\u2019Souza","year":"2023","unstructured":"D\u2019Souza S, James E, Koul A, Modak D, Kundu G, Shetty R. A randomized controlled study evaluating outcomes of intense pulsed light and low-level light therapy for treating meibomian gland dysfunction and evaporative dry eye. Indian J Ophthalmol. 2023;71(4):1608\u201312.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"510_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jtos.2020.06.002","volume":"18","author":"B Tashbayev","year":"2020","unstructured":"Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunction: a concise review. Ocul Surf. 2020;18(4):583\u201394.","journal-title":"Ocul Surf"},{"issue":"1","key":"510_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","volume":"46","author":"PY Lam","year":"2020","unstructured":"Lam PY, Shih KC, Fong PY, Chan TCY, Ng AL, Jhanji V, et al. A review on evidence-based treatments for meibomian gland dysfunction. Eye Contact Lens. 2020;46(1):3\u201316.","journal-title":"Eye Contact Lens"},{"issue":"1","key":"510_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04058-z","volume":"25","author":"J Jiang","year":"2025","unstructured":"Jiang J, Yang X, Du F, Zheng W, Wang J. The therapeutic effect of IPL on children with refractory seasonal allergic conjunctivitis. BMC Ophthalmol. 2025;25(1):217.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"510_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-025-09098-3","volume":"68","author":"J Bao","year":"2025","unstructured":"Bao J, Wen Y, Tian L, Jie Y. Decoding allergic conjunctivitis: latest perspectives on etiological drivers and immunopathological mechanisms. Clin Rev Allergy Immunol. 2025;68(1):85\u2013108.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"510_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4274\/tjo.galenos.2020.11456","volume":"51","author":"BV Villegas","year":"2021","unstructured":"Villegas BV, Benitez-del-Castillo JM. Current knowledge in allergic conjunctivitis. Turk J Ophthalmol. 2021;51(1):45\u201354.","journal-title":"Turk J Ophthalmol"},{"issue":"2","key":"510_CR60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.anai.2019.11.014","volume":"124","author":"L Bielory","year":"2020","unstructured":"Bielory L, Delgado L, Katelaris CH, Leonardi A, Rosario N, Vichyanoud P. ICON: diagnosis and management of allergic conjunctivitis. Ann Allergy Asthma Immunol. 2020;124(2):118\u201334.","journal-title":"Ann Allergy Asthma Immunol."},{"key":"510_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2024.109982","volume":"245","author":"V Barone","year":"2024","unstructured":"Barone V, Scirocco L, Surico PL, Micera A, Cutrupi F, Coassin M, et al. Mast cells and ocular surface: an update review. Exp Eye Res. 2024;245:109982.","journal-title":"Exp Eye Res"},{"issue":"3","key":"510_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.17691\/stm2025.17.3.06","volume":"17","author":"GS Igonin","year":"2025","unstructured":"Igonin GS, Svetozarskiy SN, Smetankin IG. Modern technologies in Demodex blepharitis diagnosis and therapy (review). Sovrem Tekhnol Med. 2025;17(3):62\u201373.","journal-title":"Sovrem Tekhnol Med"},{"issue":"6","key":"510_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101453","volume":"44","author":"DF Mart\u00ednez-Pulgar\u00edn","year":"2021","unstructured":"Mart\u00ednez-Pulgar\u00edn DF, \u00c1vila MY, Rodr\u00edguez-Morales AJ. Interventions for Demodex blepharitis and their effectiveness: a systematic review and meta-analysis. Contact Lens Anterior Eye. 2021;44(6):101453.","journal-title":"Contact Lens Anterior Eye"},{"issue":"3","key":"510_CR64","first-page":"167","volume":"22","author":"S Avraham","year":"2024","unstructured":"Avraham S, Khaslavsky S, Kashetsky N, Starkey SY, Zaslavsky K, Lam JM, et al. Treatment of ocular rosacea: a systematic review. J Dtsch Dermatol Ges. 2024;22(3):167\u201374.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"1","key":"510_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54161-2","volume":"14","author":"J Jiang","year":"2024","unstructured":"Jiang J, Yang X, Du F, Zheng W, Yang Y. Therapeutic effect of intense pulsed light on different types of chalazion in children. Sci Rep. 2024;14(1):3645.","journal-title":"Sci Rep"},{"issue":"1","key":"510_CR66","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00347-021-01436-y","volume":"119","author":"C Loth","year":"2022","unstructured":"Loth C, Miller CV, Haritoglou C, Messmer ESBM. Hordeolum and chalazion: (Differential) diagnosis and treatment. Ophthalmologe. 2022;119(1):97\u2013108.","journal-title":"Ophthalmologe."},{"issue":"1","key":"510_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","volume":"17","author":"R Arita","year":"2019","unstructured":"Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104\u201310.","journal-title":"Ocul Surf"},{"issue":"2","key":"510_CR68","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtos.2020.01.003","volume":"18","author":"AL Xue","year":"2020","unstructured":"Xue AL, Wang MTM, Ormonde SE, Craig JP. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf. 2020;18(2):286\u201397.","journal-title":"Ocul Surf"},{"issue":"4","key":"510_CR69","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.oftale.2025.01.002","volume":"100","author":"S Turizo Mej\u00eda","year":"2025","unstructured":"Turizo Mej\u00eda S, Jaramillo LM, Gil Mu\u00f1oz JC, Buitrago Salazar JC, Rodr\u00edguez G\u00f3mez AM, Mej\u00eda Echavarr\u00eda LF, et al. Pulsed light therapy in refractory dry eye disease associated with meibomian gland dysfunction: effectiveness in symptomatic response. Arch Soc Esp Oftalmol (Engl Ed). 2025;100(4):174\u20139.","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"},{"issue":"9","key":"510_CR70","first-page":"527","volume":"37","author":"R Toyos","year":"2019","unstructured":"Toyos R, Toyos M, Willcox J, Mulliniks H, Hoover J. Evaluation of the safety and efficacy of intense pulsed light treatment with meibomian gland expression of the upper eyelids for dry eye disease. Photobiomodul Photomed Laser Surg. 2019;37(9):527\u201331.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"1","key":"510_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-19229-7","volume":"15","author":"R Arita","year":"2025","unstructured":"Arita R, Fukuoka S. Tear film and meibomian gland parameters associated with the effectiveness of intense pulsed light therapy for meibomian gland dysfunction. Sci Rep. 2025;15(1):35390.","journal-title":"Sci Rep"},{"issue":"1","key":"510_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2025.102486","volume":"49","author":"S Dumpati","year":"2026","unstructured":"Dumpati S, Iqbal F, Vijay AK, Tan J, Kumar M, Willcox M. Intense pulsed light therapy to improve signs and symptoms of contact lens discomfort. Contact Lens Anterior Eye. 2026;49(1):102486.","journal-title":"Contact Lens Anterior Eye"},{"issue":"1","key":"510_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39332-x","volume":"13","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Zhao H, Huang X, Lin L, Huo Y, Qin Z, et al. Novel treatment of chalazion using light-guided-tip intense pulsed light. Sci Rep. 2023;13(1):12393.","journal-title":"Sci Rep"},{"key":"510_CR74","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/OPTH.S213664","volume":"13","author":"K Stonecipher","year":"2019","unstructured":"Stonecipher K, Abell TG, Chotiner B, Chotiner E, Potvin R. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993\u20139.","journal-title":"Clin Ophthalmol"},{"key":"510_CR75","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2147\/OPTH.S307020","volume":"15","author":"MA P\u00e9rez-Silguero","year":"2021","unstructured":"P\u00e9rez-Silguero MA, P\u00e9rez-Silguero D, Rivero-Santana A, Bernal-Blasco MI, Encinas-Pisa P. Combined intense pulsed light and low-level light therapy for the treatment of dry eye: a retrospective before\u2013after study with one-year follow-up. Clin Ophthalmol. 2021;15:2133\u201340.","journal-title":"Clin Ophthalmol"},{"key":"510_CR76","doi-asserted-by":"publisher","DOI":"10.1177\/11206721221127206","author":"A Meduri","year":"2022","unstructured":"Meduri A, Oliverio GW, Tedesco G, Aragona P. Combined intense pulsed light and low-level light therapy for the treatment of refractory meibomian gland dysfunction. Eur J Ophthalmol. 2022:11206721221127206. https:\/\/doi.org\/10.1177\/11206721221127206.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"510_CR77","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/cimb45030122","volume":"45","author":"YL Du","year":"2023","unstructured":"Du YL, Peng X, Liu Y, Wang JS, Ye YF, Xu KK, et al. Ductal hyperkeratinization and acinar renewal abnormality: new concepts on pathogenesis of meibomian gland dysfunction. Curr Issues Mol Biol. 2023;45(3):1889\u2013901.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"510_CR78","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/09273948.2020.1755441","volume":"29","author":"S Hassanzadeh","year":"2021","unstructured":"Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, Heravian Shandiz J, Azimi Khorasani A. Global prevalence of meibomian gland dysfunction: a systematic review and meta-analysis. Ocul Immunol Inflamm. 2021;29(1):66\u201375.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"510_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/02713683.2023.2279014","volume":"49","author":"B Tashbayev","year":"2024","unstructured":"Tashbayev B, Chen X, Utheim TP. Chalazion treatment: a concise review of clinical trials. Curr Eye Res. 2024;49(2):109\u201318.","journal-title":"Curr Eye Res"},{"issue":"5","key":"510_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051427","volume":"11","author":"Y Wu","year":"2022","unstructured":"Wu Y, Jiang H, Zhou X, Zhai Z, Yang P, Zhou S, et al. Morphological and functional changes of meibomian glands in pediatric and adult patients with allergic conjunctivitis. J Clin Med. 2022;11(5):1427.","journal-title":"J Clin Med"},{"issue":"12","key":"510_CR81","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1038\/s41433-021-01526-w","volume":"35","author":"P Hossain","year":"2021","unstructured":"Hossain P. Reducing the burden of ocular surface disease with serum eye drops. Eye (Lond). 2021;35(12):3179\u201380.","journal-title":"Eye (Lond)"},{"issue":"11","key":"510_CR82","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1007\/s10792-022-02330-5","volume":"42","author":"HS Chung","year":"2022","unstructured":"Chung HS, Rhim JW, Park JH. Combination treatment with intense pulsed light, thermal pulsation (LipiFlow), and meibomian gland expression for refractory meibomian gland dysfunction. Int Ophthalmol. 2022;42(11):3311\u20139.","journal-title":"Int Ophthalmol"},{"key":"510_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.973962","volume":"13","author":"H Yu","year":"2022","unstructured":"Yu H, Zeng W, Zhao G, Hong J, Feng Y. Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye. Front Endocrinol (Lausanne). 2022;13:973962.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"510_CR84","doi-asserted-by":"publisher","first-page":"238","DOI":"10.21037\/atm-20-1745","volume":"9","author":"Y Huo","year":"2021","unstructured":"Huo Y, Mo Y, Wu Y, Fang F, Jin X. Therapeutic effect of intense pulsed light with optimal pulse technology on meibomian gland dysfunction with and without ocular Demodex infestation. Ann Transl Med. 2021;9(3):238.","journal-title":"Ann Transl Med"},{"issue":"2","key":"510_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/a-1942-2007","volume":"240","author":"A Suwal","year":"2023","unstructured":"Suwal A, Hao J, Liu X, Zhou D, Jia Z, Liu H, et al. Effect of intense pulsed light to mitigate meibomian gland dysfunction for dry eye disease. Klin Monatsbl\u00e4tter Augenheilkd. 2023;240(2):163\u20138.","journal-title":"Klin Monatsbl\u00e4tter Augenheilkd."},{"issue":"7","key":"510_CR86","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.21037\/apm-21-1303","volume":"10","author":"S Yan","year":"2021","unstructured":"Yan S, Wu Y. Efficacy and safety of intense pulsed light therapy for dry eye caused by meibomian gland dysfunction: a randomised trial. Ann Palliat Med. 2021;10(7):7857\u201365.","journal-title":"Ann Palliat Med"},{"issue":"49","key":"510_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000046248","volume":"104","author":"Y Lu","year":"2025","unstructured":"Lu Y, Tong Y, Feng C. Comparison of the efficacy of intense pulsed light, 0.05% cyclosporine A eye drops, and 3% diquafosol sodium eye drops in the treatment of moderate to severe dry eye: a prospective cohort study. Medicine (Baltimore). 2025;104(49):e46248.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"510_CR88","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/02713683.2023.2297344","volume":"49","author":"Y Lu","year":"2024","unstructured":"Lu Y, Gong L, Yin Y. Need to increase the number of intense pulsed light (IPL) treatment sessions for patients with moderate to severe meibomian gland dysfunction (MGD) patients. Curr Eye Res. 2024;49(4):362\u20137.","journal-title":"Curr Eye Res"},{"issue":"7","key":"510_CR89","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.oftal.2019.04.003","volume":"94","author":"V Moris Garc\u00eda","year":"2019","unstructured":"Moris Garc\u00eda V, Valenzuela Vargas G, Mar\u00edn Cornuy M, Aguila Torres P. Demodicosis ocular: una revisi\u00f3n. Arch Soc Esp Oftalmol (Engl Ed). 2019;94(7):316\u201322.","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"8","key":"510_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/ICL.0000000000001003","volume":"49","author":"MK Rhee","year":"2023","unstructured":"Rhee MK, Yeu E, Barnett M, Rapuano CJ, Dhaliwal DK, Nichols KK, et al. Demodex blepharitis: a comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49(8):311\u20138.","journal-title":"Eye Contact Lens"},{"key":"510_CR91","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2147\/OPTH.S374530","volume":"16","author":"L O\u2019Dell","year":"2022","unstructured":"O\u2019Dell L, Dierker DS, Devries DK, Garlich J, Whitley WO, Holdbrook M, et al. Psychosocial impact of Demodex blepharitis. Clin Ophthalmol. 2022;16:2979\u201387.","journal-title":"Clin Ophthalmol"},{"key":"510_CR92","doi-asserted-by":"publisher","first-page":"9204251","DOI":"10.1155\/2022\/9204251","volume":"2022","author":"L Capasso","year":"2022","unstructured":"Capasso L, Abbinante G, Coppola A, Salerno G, De Bernardo M. Recent evidence of tea tree oil effectiveness in blepharitis treatment. Biomed Res Int. 2022;2022:9204251.","journal-title":"Biomed Res Int."},{"issue":"3","key":"510_CR93","first-page":"178","volume":"39","author":"S Zhang-Nunes","year":"2021","unstructured":"Zhang-Nunes S, Guo S, Lee D, Chang J, Nguyen A. Safety and efficacy of an augmented intense pulse light protocol for dry eye syndrome and blepharitis. Photobiomodul Photomed Laser Surg. 2021;39(3):178\u201384.","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"3","key":"510_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030710","volume":"13","author":"A Di Zazzo","year":"2024","unstructured":"Di Zazzo A, Giannaccare G, Villani E, Barabino S. Uncommon blepharitis. J Clin Med. 2024;13(3):710.","journal-title":"J Clin Med"},{"key":"510_CR95","doi-asserted-by":"publisher","first-page":"1454049","DOI":"10.3389\/fmed.2024.1454049","volume":"11","author":"HJ Yoon","year":"2024","unstructured":"Yoon HJ, Moon JY, Yoon KC. Efficacy of combined doxycycline and intense pulsed light therapy for the management of intractable recurrent chalazion. Front Med (Lausanne). 2024;11:1454049.","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"510_CR96","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/ICO.0000000000003785","volume":"44","author":"K Mohamed-Noriega","year":"2025","unstructured":"Mohamed-Noriega K, Loya-Garcia D, Vera-Duarte GR, Morales-Wong F, Ortiz-Morales G, Navas A, et al. Ocular rosacea: an updated review. Cornea. 2025;44(4):525\u201337.","journal-title":"Cornea"},{"issue":"6","key":"510_CR97","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jcjo.2025.04.005","volume":"60","author":"RH Kirkpatrick","year":"2025","unstructured":"Kirkpatrick RH, Nazzicone K, Biorac A, Froentjes AR, Simpson SM, Molin S. Prevalence of ocular manifestations in cutaneous rosacea: systematic review and meta-analysis. Can J Ophthalmol. 2025;60(6):330\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"510_CR98","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1159\/000522494","volume":"238","author":"SP Sinikumpu","year":"2022","unstructured":"Sinikumpu SP, V\u00e4h\u00e4nikkil\u00e4 H, Jokelainen J, Tasanen K, Huilaja L. Ocular symptoms and rosacea: a population-based study. Dermatology. 2022;238(5):846\u201350.","journal-title":"Dermatology"},{"issue":"13","key":"510_CR99","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.13.22","volume":"64","author":"N Yesilirmak","year":"2023","unstructured":"Yesilirmak N, Bukan N, Kurt B, Yuzbasioglu S, Zhao M, Rodrigues-Braz D, et al. Evaluation of ocular and systemic oxidative stress markers in ocular rosacea patients. Invest Ophthalmol Vis Sci. 2023;64(13):22.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"510_CR100","first-page":"357","volume":"29","author":"N Yesilirmak","year":"2023","unstructured":"Yesilirmak N, Bukan N, Kurt B, Fatsa T, Yuzbas\u0131oglu S, Zhao M, et al. Toll-like receptor-4 expression and oxidative stress in ocular rosacea. Mol Vis. 2023;29:357\u201364.","journal-title":"Mol Vis"},{"issue":"1","key":"510_CR101","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00347-020-01279-z","volume":"118","author":"DA Starosta","year":"2021","unstructured":"Starosta DA, Lorenz B. Pediatric ocular rosacea effectively treated with topical 1.5% azithromycin eye drops. Ophthalmologe. 2021;118(1):68\u201373.","journal-title":"Ophthalmologe."},{"issue":"8","key":"510_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70357","volume":"24","author":"S Menashe","year":"2025","unstructured":"Menashe S, Bermejo IG, Lois M, Molinari LM, Reig MI. Effective treatment of rosacea and telangiectasias using IPL. J Cosmet Dermatol. 2025;24(8):e70357.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"510_CR103","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1684\/ejd.2022.4301","volume":"32","author":"C Verg\u00e9s","year":"2022","unstructured":"Verg\u00e9s C, March de Ribot F, Salgado-Borges J, Gonzalez J. Prospective evaluation of intense pulsed light treatment for meibomian gland dysfunction and blepharitis due to ocular rosacea. Eur J Dermatol. 2022;32(4):505\u201315.","journal-title":"Eur J Dermatol."},{"issue":"11","key":"510_CR104","first-page":"1005","volume":"36","author":"K Yang","year":"2023","unstructured":"Yang K, Wen Y, Zhu L, Bao JY, Li S, Wang YH, et al. The effect of intense pulsed light treatment for chronic hordeolum. Biomed Environ Sci. 2023;36(11):1005\u201314.","journal-title":"Biomed Environ Sci."},{"issue":"4","key":"510_CR105","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/11206721251330146","volume":"35","author":"T Kornhauser","year":"2025","unstructured":"Kornhauser T, Elhusseiny AM, Pemberton JD. Management strategies for chalazia in pediatric patients: a scoping review. Eur J Ophthalmol. 2025;35(4):1481\u201394.","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"510_CR106","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.4103\/IJO.IJO_3186_22","volume":"71","author":"L Gan","year":"2023","unstructured":"Gan L, Liu Y, Zhou X, Xue K, Guo J, Qian J, et al. Extralesional triamcinolone acetonide injection in the treatment of small chalazion. Indian J Ophthalmol. 2023;71(8):2959\u201361.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"510_CR107","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/ICL.0000000000000859","volume":"48","author":"AF Alsoudi","year":"2022","unstructured":"Alsoudi AF, Ton L, Ashraf DC, Idowu OO, Kong AW, Wang L, et al. Efficacy of care and antibiotic use for chalazia and hordeola. Eye Contact Lens. 2022;48(4):162\u20138.","journal-title":"Eye Contact Lens"},{"issue":"18","key":"510_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11185338","volume":"11","author":"R Arita","year":"2022","unstructured":"Arita R, Fukuoka S. Therapeutic efficacy and safety of intense pulsed light for refractive multiple recurrent chalazia. J Clin Med. 2022;11(18):5338.","journal-title":"J Clin Med"},{"issue":"9","key":"510_CR109","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.oftale.2022.06.008","volume":"97","author":"A Caravaca","year":"2022","unstructured":"Caravaca A, Ali\u00f3 Del Barrio JL, Mart\u00ednez Hergueta MC, Amesty MA. Intense pulsed light combined with meibomian gland expression for chalazion management. Arch Soc Esp Oftalmol (Engl Ed). 2022;97(9):490\u20136.","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"},{"issue":"2","key":"510_CR110","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/lsm.10145","volume":"32","author":"C Raulin","year":"2003","unstructured":"Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32(2):78\u201387.","journal-title":"Lasers Surg Med"},{"issue":"4","key":"510_CR111","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1111\/aos.15759","volume":"102","author":"F Fineide","year":"2024","unstructured":"Fineide F, Magn\u00f8 MS, Khan AZ, Chen X, Vehof J, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunction: past, present, and future. Acta Ophthalmol (Copenh). 2024;102(4):e414-42.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"510_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14010199","volume":"14","author":"H Lee","year":"2025","unstructured":"Lee H, Jeon YY, Eah KS, Park N, Lee YE, Han J, et al. A comparative study of intense pulsed light with two different filters in meibomian gland dysfunction: a prospective randomized study. J Clin Med. 2025;14(1):199.","journal-title":"J Clin Med"},{"issue":"1","key":"510_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33526-z","volume":"13","author":"JH Jang","year":"2023","unstructured":"Jang JH, Lee K, Nam SH, Kim J, Kim JY, Tchah H, et al. Comparison of clinical outcomes between intense pulsed light therapy using two different filters in meibomian gland dysfunction: prospective randomized study. Sci Rep. 2023;13(1):6700.","journal-title":"Sci Rep"},{"issue":"7","key":"510_CR114","volume":"15","author":"C Castro","year":"2023","unstructured":"Castro C, Marques JH, Marta A, Baptista PM, Jos\u00e9 D, Sousa P, et al. Comparison of light-based devices in the treatment of meibomian gland dysfunction. Cureus. 2023;15(7):e41386.","journal-title":"Cureus"},{"issue":"10","key":"510_CR115","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s40123-024-01017-7","volume":"13","author":"CP Pac","year":"2024","unstructured":"Pac CP, Munteanu M, S\u00e1nchez-Gonz\u00e1lez J-M, Rocha-de-Lossada C, Mercea N, Ferrari F, et al. Long-term impacts of intense pulsed light therapy on ocular surface health and tear film dynamics in patients with dry eye disease: detailed analysis and observations over a 1-year follow-up period. Ophthalmol Ther. 2024;13(10):2715\u201330.","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"510_CR116","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3341\/kjo.2022.0068","volume":"36","author":"SH Lee","year":"2022","unstructured":"Lee SH, Kim M, Lee WJ, Chun YS, Kim KW. Different number of sessions of intense pulsed light and meibomian gland expression combination therapy for meibomian gland dysfunction. Korean J Ophthalmol. 2022;36(6):527\u201342.","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"510_CR117","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1167\/iovs.11-9228","volume":"53","author":"E Viso","year":"2012","unstructured":"Viso E, Rodr\u00edguez-Ares MT, Abelenda D, Oubi\u00f1a B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53(6):2601\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"510_CR118","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/ICO.0000000000003774","volume":"44","author":"M Safir","year":"2025","unstructured":"Safir M, Rabina G, Arbel I, Sharon Y, Spierer O, Mimouni M, et al. Ivermectin 1% combined with intense pulsed light treatment for dry eye disease secondary to Demodex blepharitis. Cornea. 2025;44(10):1273\u20137.","journal-title":"Cornea"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-026-00510-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-026-00510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:03:51Z","timestamp":1790816631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40662-026-00510-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1186\/s40662-026-00510-3","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"41"}}